2025. SEMAGLUTIDE IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME: CURRENT EVIDENCE AND REPRODUCTIVE BENEFITS. International Journal of Innovative Technologies in Social Science. 4, 3(47) (Sep. 2025). DOI:https://doi.org/10.31435/ijitss.3(47).2025.3940.